DouglasASimonettoMD(He/Him)
Gastroenterology • Rochester, MNHepatology & Liver Transplantation
Associate Professor of Medicine
Dr. Simonetto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2015 - 2016- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2012 - 2015
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
Hlth Scis Fed Univ Porto AlegreClass of 2007
Certifications & Licensure
MN State Medical License 2011 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Acamprosate Safe to Use in Individuals With Liver Disease. Start of enrollment: 2020 Sep 21
Publications & Presentations
PubMed
- Forecasting Alcohol-Related Liver Disease Mortality Trends in Younger Populations Using Advanced Time-Series Models: A 1999-2030 Analysis.Hassam Ali, Vinay Jahagirdar, Hanna Blaney, Dushyant Singh Dahiya, Manesh K Gangwani
JGH Open. 2024-12-01 - 1 citationsPulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.Kelly M Pennington, Douglas Simonetto, Timucin Taner, Abhishek A Mangaonkar
Current Hematologic Malignancy Reports. 2024-12-01 - 1 citationsLiver transplantation for alcohol-associated liver disease.Douglas A Simonetto, Gerald Scott Winder, Ashton A Connor, Norah A Terrault
Hepatology. 2024-12-01
Journal Articles
- Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta‐AnalysisDouglas A Simonetto, Mohammad Hassan Murad, Siddharth Singh, Patrick S Kamath, Hepatology
Press Mentions
PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024- PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024
- Surge in Alcohol-Related Disease During Pandemic Reveals Unmet Need for TreatmentMay 31st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
